Liver Cancer Immunotherapy
Cancer immunotherapy is changing the outlook for patients diagnosed with different types of liver cancer
Immunotherapy for liver cancer offers some of the greatest new treatment options for patients. There are three main types of liver cancer: hepatocellular carcinoma (HCC), cholangiosarcoma, and hepatoblastoma. Rarer subtypes do occur within these categories, such as fibrolamellar hepatocellular carcinoma, which are also eligible for treatment with immunotherapy based on the individual patient’s likelihood to respond.
Liver cancers are diagnosed in more than 800,000 people around the world each year and is one of the leading causes of cancer deaths globally.
In this breakout session from the 2022 CRI Virtual Immunotherapy Patient Summit, Dr. Theodore Welling from the Perlmutter Cancer Center at NYU Health discusses the latest updates in immunotherapy treatments for patients with these and other types of liver cancer.
Skin Cancer and Melanoma Immunotherapy
Understanding and Overcoming Barriers to Accessing Cancer Care
Blood Cancer Immunotherapy
Breast Cancer Immunotherapy
Colorectal Cancer Immunotherapy
Kidney Cancer Immunotherapy
Lung Cancer Immunotherapy
Pancreatic Cancer Immunotherapy
Prostate Cancer Immunotherapy
Intro to CRI
Cancer Immunotherapy Basics: Harnessing Our Immune System to Fight Cancer
Clinical Trials and Cancer Immunotherapy: Accessing Promising Treatments
Patient Perspectives: Immunotherapy and Clinical Trial Experiences
Bladder Cancer Immunotherapy
Gynecologic Cancer Immunotherapy
Hosts
Tamron Hall
Award-Winning TV Host, Journalist, Executive Producer, and Philanthropist
CRI Experts
Julie Brahmer, MD
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Andrea Cercek, MD
Memorial Sloan Kettering Cancer Center
Luis Diaz Jr., MD
Memorial Sloan Kettering Cancer Center
Peter E. Fecci, MD, PhD
Duke Cancer Center, DukeHealth, and Duke University
Lawrence Fong, MD
UCSF Helen Diller Family Comprehensive Cancer Center
Matthew D. Galsky, MD
The Tisch Cancer Institute
Sangeeta Goswami, MD, PhD
The University of Texas MD Anderson Cancer Center
Elizabeth Ann Mittendorf, MD, PhD
Dana-Farber/Harvard Cancer Center
Kunle Odunsi, MD, PhD
University of Chicago Medicine Comprehensive Cancer Center
Joseph E. Ravenell, MD
Perlmutter Cancer Center NYU Langone Health
Marcel van den Brink, MD, PhD
Memorial Sloan Kettering Cancer Center
Ana I. Velázquez Mañana, MD MSc
UCSF Helen Diller Family Comprehensive Cancer Center
Robert H. Vonderheide, MD, DPhil
University of Pennsylvania Health System
Jennifer Wargo, MD, MMSc
The University of Texas MD Anderson Cancer Center
Jeffrey S. Weber, MD, PhD
Perlmutter Cancer Center NYU Langone Health
Theodore H. Welling, MD
Perlmutter Cancer Center NYU Langone Health
CRI ImmunoAdvocates
LaToya Bolds-Johnson, PA-C, CAQ-EM
Breast Cancer Advocate & Thriver
Stephen Estrada
Long-term Survivor of Stage 4 Colorectal Cancer
Stephanie Gangi
Breast Cancer Navigator
Sunshine Pegues
Lung Cancer Veteran
John White
Prostate Cancer Veteran
CRI Moderators
Brian Brewer
Cancer Research Institute
Sponsors
Gold
Silver
Contributor
Friend
Host Institutions
Questions?
Contact
patients@cancerresearch.org